Therefore, the percentages of apoptotic cells were determined using annexin V/PI staining, once CD34+ cells from patients with CML in the megakaryocytic and myeloid crisis phases had been exposed to imatinib for 24 to 72 h. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.